REMISSION OF GRAVES DISEASE AFTER INITIATION OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS. Casany-Fernandez R, Gascon-Gimenez F, Matarredona Solaz EJ, Pardo Lozano F, et al. Thyroid 2022 Nov 23. doi: 10.1089/thy.2022.0398.

Read + Share

Amedeo Smart

Independent Medical Education

Casany-Fernandez R, Gascon-Gimenez F, Matarredona Solaz EJ, Pardo Lozano F, et al. REMISSION OF GRAVES DISEASE AFTER INITIATION OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS. Thyroid 2022 Nov 23. doi: 10.1089/thy.2022.0398.
PMID: 36416241